AstraZeneca PLC- 詳細介紹、公司背景、業務範圍、財務數據以及市場表現

關於 AstraZeneca PLC 公司

公司簡介

公司代碼AZN

公司名稱AstraZeneca PLC

上市日期Sep 21, 2007

成立日期1992

CEOMr. Marc Dunoyer

員工數量94300

證券類型Ordinary Share

年結日Sep 21

公司地址1 Francis Crick Avenue

城市CAMBRIDGE

上市交易所London Stock Exchange

國家United Kingdom

郵編CB2 0AA

電話442073045000

網址https://www.astrazeneca.com/

公司代碼AZN

上市日期Sep 21, 2007

成立日期1992

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Ms. Susan Galbraith

Executive Vice President - Oncology and Research and Development

--

Mr. Marc Dunoyer

Chief Executive Officer - Alexion, Chief Strategy Officer - AstraZeneca

--

Mr. David (Dave) Fredrickson

Executive Vice President - Oncology Business Unit

--

Mr. Pascal Soriot

Chief Executive Officer, Executive Director

--

Mr. Philip Broadley

Senior Non-Executive Independent Director

--

Dr. Ruud Dobber, Ph.D.

Executive Vice President - BioPharmaceuticals Business Unit

--

Ms. Deborah Disanzo Eldracher

Non-Executive Independent Director

--

Ms. Diana Layfield

Non-Executive Independent Director

--

Mr. Rene Haas

Non-Executive Director

--

Mr. Michel Demare

Non-Executive Independent Chairman of the Board

--

名稱

名稱/職務

職務

持股

持股變動

Ms. Susan Galbraith

Executive Vice President - Oncology and Research and Development

--

Mr. Marc Dunoyer

Chief Executive Officer - Alexion, Chief Strategy Officer - AstraZeneca

--

Mr. David (Dave) Fredrickson

Executive Vice President - Oncology Business Unit

--

Mr. Pascal Soriot

Chief Executive Officer, Executive Director

--

Mr. Philip Broadley

Senior Non-Executive Independent Director

--

Dr. Ruud Dobber, Ph.D.

Executive Vice President - BioPharmaceuticals Business Unit

--

收入明細

單位: USD更新時間: 3月5日週三

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Farxiga

7.65B

15.03%

Tagrisso

6.58B

12.91%

Imfinzi

4.71B

9.26%

Ultomiris

3.92B

7.70%

Calquenc

3.12B

6.14%

Other

24.93B

48.94%

地區USD

名稱

營收

佔比

United States

21.80B

42.80%

China

6.41B

12.60%

United Kingdom

4.74B

9.30%

Other European Countries

3.66B

7.19%

Japan

3.45B

6.77%

Other

10.85B

21.31%

業務

地區

業務USD

名稱

營收

佔比

Farxiga

7.65B

15.03%

Tagrisso

6.58B

12.91%

Imfinzi

4.71B

9.26%

Ultomiris

3.92B

7.70%

Calquenc

3.12B

6.14%

Other

24.93B

48.94%

股東統計

更新時間: 2月21日週五

持股股東

股東類型

持股股東

股東統計

佔比

PRIMECAP Management Company

1.32%

Capital International Investors

1.20%

Wellington Management Company, LLP

1.19%

T. Rowe Price Associates, Inc.

1.08%

T. Rowe Price International Ltd

0.85%

Other

94.32%

持股股東

股東統計

佔比

PRIMECAP Management Company

1.32%

Capital International Investors

1.20%

Wellington Management Company, LLP

1.19%

T. Rowe Price Associates, Inc.

1.08%

T. Rowe Price International Ltd

0.85%

Other

94.32%

股東類型

股東統計

佔比

Investment Advisor

9.43%

Investment Advisor/Hedge Fund

6.01%

Hedge Fund

0.96%

Research Firm

0.88%

Bank and Trust

0.14%

Holding Company

0.07%

Pension Fund

0.04%

Venture Capital

0.02%

Family Office

0.01%

Other

82.39%

機構持股

更新時間: 1月19日週日

報告期間

機構數

持股數

持股佔比

持股變動

2025Q1

1935

545.66M

17.59%

+11.80M

2024Q4

1985

546.16M

17.61%

+11.21M

2024Q3

1920

519.94M

16.76%

-17.36M

2024Q2

1910

530.79M

17.12%

-10.50M

2024Q1

1865

523.00M

16.86%

-21.20M

2023Q4

1838

520.78M

16.79%

-27.27M

2023Q3

1815

530.16M

17.10%

-14.80M

2023Q2

1812

525.35M

16.94%

-28.73M

2023Q1

1803

534.30M

17.23%

-35.06M

2022Q4

1806

550.26M

17.75%

-33.14M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

PRIMECAP Management Company

41.01M

1.32%

-960.51K

-2.28%

Dec 31, 2024

Capital International Investors

37.50M

1.2%

+686.00K

+1.86%

Dec 31, 2024

Wellington Management Company, LLP

37.03M

1.19%

-208.19K

-0.55%

Dec 31, 2024

T. Rowe Price Associates, Inc.

33.74M

1.08%

-3.07M

-8.34%

Dec 31, 2024

T. Rowe Price International Ltd

26.60M

0.85%

+530.21K

+2.03%

Dec 31, 2024

Fidelity Management & Research Company LLC

18.14M

0.58%

-1.09M

-5.70%

Dec 31, 2024

Managed Account Advisors LLC

15.80M

0.5%

+7.65M

+93.93%

Dec 31, 2024

Jennison Associates LLC

15.43M

0.49%

+466.41K

+3.11%

Dec 31, 2024

Sanders Capital, LLC

15.18M

0.48%

+212.30K

+1.41%

Dec 31, 2024

Invesco Capital Management (QQQ Trust)

11.80M

0.38%

+233.78K

+2.01%

Dec 31, 2024

持股ETF

更新時間: 13 小時前

機構名稱

佔比

First Trust WCM International Equity ETF

5.11%

VanEck Pharmaceutical ETF

4.9%

Amplify Weight Loss Drug & Treatment ETF

4.51%

Roundhill GLP-1 & Weight Loss ETF

4.38%

ProShares Ultra Nasdaq Biotechnology

4.04%

Invesco Nasdaq Biotechnology ETF

3.82%

PGIM Jennison Focused Value ETF

3.4%

Franklin Genomic Advancements ETF

2.9%

Global X Aging Population ETF

2.77%

Amplify International Enhanced Dividend Income ETF

2.33%

First Trust WCM International Equity ETF

佔比5.11%

VanEck Pharmaceutical ETF

佔比4.9%

Amplify Weight Loss Drug & Treatment ETF

佔比4.51%

Roundhill GLP-1 & Weight Loss ETF

佔比4.38%

ProShares Ultra Nasdaq Biotechnology

佔比4.04%

Invesco Nasdaq Biotechnology ETF

佔比3.82%

PGIM Jennison Focused Value ETF

佔比3.4%

Franklin Genomic Advancements ETF

佔比2.9%

Global X Aging Population ETF

佔比2.77%

Amplify International Enhanced Dividend Income ETF

佔比2.33%

分紅派息

近5年累計派現 20.90B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Feb 06, 2025

AZN.NB Interim Cash Dividend of gross USD 1.05 paid on Mar 24, 2025 going ex on Feb 21, 2025

Feb 21, 2025

Mar 24, 2025

Feb 21, 2025

Jul 25, 2024

AZN.NB Final Cash Dividend of gross USD 0.5 paid on Sep 09, 2024 going ex on Aug 09, 2024

Aug 09, 2024

Sep 09, 2024

Aug 09, 2024

Feb 08, 2024

AZN.NB Interim Cash Dividend of gross USD 0.985 paid on Mar 25, 2024 going ex on Feb 22, 2024

Feb 23, 2024

Mar 25, 2024

Feb 22, 2024

Jul 28, 2023

AZN.NB Final Cash Dividend of gross USD 0.465 paid on Sep 11, 2023 going ex on Aug 10, 2023

Aug 11, 2023

Sep 11, 2023

Aug 10, 2023

Feb 10, 2023

AZN.NB Interim Cash Dividend of gross USD 0.985 paid on Mar 27, 2023 going ex on Feb 23, 2023

Feb 24, 2023

Mar 27, 2023

Feb 23, 2023

Aug 01, 2022

AZN.NB Final Cash Dividend of gross USD 0.465 paid on Sep 12, 2022 going ex on Aug 11, 2022

Aug 12, 2022

Sep 12, 2022

Aug 11, 2022

Feb 10, 2022

AZN.NB Interim Cash Dividend of gross USD 0.985 paid on Mar 28, 2022 going ex on Feb 24, 2022

Feb 25, 2022

Mar 28, 2022

Feb 24, 2022

Aug 02, 2021

AZN.NB Final Cash Dividend of gross USD 0.45 paid on Sep 13, 2021 going ex on Aug 12, 2021

Aug 13, 2021

Sep 13, 2021

Aug 12, 2021

Feb 11, 2021

AZN.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2021 going ex on Feb 25, 2021

Feb 26, 2021

Mar 29, 2021

Feb 25, 2021

Jul 30, 2020

AZN.NB Final Cash Dividend of gross USD 0.45 paid on Sep 14, 2020 going ex on Aug 13, 2020

Aug 14, 2020

Sep 14, 2020

Aug 13, 2020

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

AstraZeneca PLC

77.960USD

AstraZeneca PLC

77.960

概覽

公司